Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bitdeer Technologies Group (BTDR) vs Cassava Sciences Inc (FLNA) Price & Performance

Bitdeer Technologies GroupTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Bitdeer Technologies Group vs Cassava Sciences Inc — how do they compare? Bitdeer Technologies Group trades at $8.85 (market cap $2.12B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Bitdeer Technologies Group is far larger — about 44.4× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.

BTDRFLNA
Market Cap
$2.12B$47.75M
Sector
TechnologyHealth
52-Week High
$25.90$4.64
52-Week Low
$7.28$0.87
Enterprise Value
$3.88B-$34.93M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bitdeer Technologies Group

BTDR trades at $10.88, up 3.42% today, but remains under bearish technical pressure with recent earnings misses. Revenue grew to $620.25M in 2025, yet net income margin turned negative at -26.96% in 2026. The company secured a significant $4.7B AI data center deal, expanding beyond Bitcoin mining. Analyst consensus is strongly bullish with an 81.82% buy rating and a $22.71 price target, suggesting over 100% upside from current levels.

Outlook: High growth potential from AI infrastructure expansion contrasts with profitability challenges and negative cash flow. Risks include execution on new contracts and persistent earnings volatility. The stock offers speculative upside if operational improvements align with analyst optimism.

Cassava Sciences Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bitdeer Technologies Group

Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.

Read more on BTDR

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA